Lightsense Technology, The Leader in Advanced Miniaturized High-Sensitivity Spectrometer Designs is currently running a new Equity Crowdfunding Campaign.

9th Sep 2022 Tucson, Arizona — Lightsense Technology, whose multi-spectroscopic solutions address significant problems in public health like the opioid crisis, pandemics, and food safety, has recently launched an equity crowdfunding campaign on Start Engine. 

With the invention of the patented “Enhanced Photodetection Spectroscopy” (EPS), Lightsense has developed a completely new spectroscopy architecture for chemical, molecular, and pathogen identification. Miniaturized high-sensitivity spectrometers enable new lightweight and inexpensive handheld devices that support law enforcement organizations. The devices can be used in various large vertical markets in “public health,” including rapid detection of illicit drugs and screening for viral/bacterial pathogens.

light image

“At Lightsense, we use optics, along with machine learning and analysis, to provide better solutions for critical areas of public health like food safety, the overuse of antibiotics, and the opioid crisis. That’s why we developed a revolutionary new multispectral technology platform to redefine spectroscopy – providing a new generation of spectroscopic tools for analyzing materials and biological systems. Our company is just starting small revenue sales in Law enforcement for our new fentanyl detector, and in R&D prototyping stages for other markets and products, with multiple patents and partnership paths underway,” states Bruce Berkoff, CMO of Lightsense Technology.

“By focusing on new techniques for sample preparation and data analysis, as well as advances in sensors and machine learning algorithms, we enable totally new solutions in areas of public health concerns with very high sensitivity and easy-to-use products that are efficient and low-cost” Berkoff adds.

By providing a new tool for law enforcement, this platform can help combat the opioid epidemic by identifying a particular threat quickly, allowing them to do their job more efficiently and with less exposure to risks. In addition, this new technology, EPS (Enhanced Photodetection Spectroscopy), can detect things like Coronavirus in human saliva within seconds, not hours, thus enabling new approaches to pandemics and healthcare.

INVEST in a better future for us all, see our new campaign page for our SEED round with StartEngine, at,

About Lightsense Technology:

Lightsense has developed groundbreaking multispectral technology platforms, such as the patented “Enhanced Photodetection Spectroscopy” (EPS), a radical new spectroscopy architecture, for chemical, molecular, and pathogen identification. Their advanced miniaturized high-sensitivity spectrometer designs also enable new lightweight and inexpensive handheld devices to support solutions for law enforcement organizations and beyond. These devices can address critical analytical and detection problems in a wide range of large vertical markets in “public health,” such as rapid detection of illicit drugs, rapid screening for viral/bacterial pathogens, and more.

Learn more at

Media Contact

Company Name: Lightsense Technology

Contact Person:  Bruce Berkoff

Phone:  1-888-736-7349, Ext 701


Address: 9420, E Golf Links Road, STE 108-179, Tucson, AZ

City: Tucson, Arizona

Email: [email protected]

Country: United States

Read More